The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits visceral obesity and insulin resistance by upregulating visceral adipose genes involved in fatty acid oxidation

References

• Bijland S, Mancini SJ, Salt IP. (2013). Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin Sci 124:491–507
   PubMed Web of Science ®Google Scholar
• Boozer CN, Nasser JA, Heymsfield SB, et al. (2001). An herbal supplement containing Ma Huang–Guarana for weight loss: A randomized, double-blind trial. Int J Obes 25:316–24
   PubMed Web of Science ®Google Scholar
• Brunzell JD, Hokanson JE. (1999). Dyslipidemia of central obesity and insulin resistance. Diabetes Care 22:C10–3
   PubMed Web of Science ®Google Scholar
• Cabrero A, Alegret M, Sánchez RM, et al. (2001). Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes. Diabetes 50:1883–90
   PubMed Web of Science ®Google Scholar
• Camp HS, Ren D, Leff T. (2002). Adipogenesis and fat-cell function in obesity and diabetes. Trends Mol Med 8:442–7
   PubMed Web of Science ®Google Scholar
• de Souza CJ, Eckhardt M, Gagen K, et al. (2001). Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 50:1863–71
   PubMed Web of Science ®Google Scholar
• Díez JJ, Iglesias P. (2003). The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293–300
   PubMed Web of Science ®Google Scholar
• Dunmore SJ, Brown JE. (2013). The role of adipokines in β-cell failure of type 2 diabetes. J Endocrinol 216:T37–45
   PubMed Web of Science ®Google Scholar
• Hardie DG. (2008). AMPK: A key regulator of energy balance in the single cell and the whole organism. Int J Obes 32:S7–12
   PubMed Web of Science ®Google Scholar
• Hrnciar J. (1993). Methods of measuring hyperinsulinism and insulin resistance. Vnitr Lek 39:481–6
   PubMedGoogle Scholar
• Huang L, Wen K, Gao X, Liu Y. (2010). Hypolipidemic effect of fucoidan from Laminaria japonica in hyperlipidemic rats. Pharm Biol 48:422–6
   PubMed Web of Science ®Google Scholar
• Jensen MD. (2006). Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity 14:20S–4
   PubMed Web of Science ®Google Scholar
• Jeong S, Yoon M. (2009). Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice. Exp Mol Med 41:397–405
   PubMed Web of Science ®Google Scholar
• Kadowaki T. (2000). Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 106:459–65
   PubMed Web of Science ®Google Scholar
• Kemp BE, Mitchelhill KI, Stapleton D, et al. (1999). Dealing with energy demand: The AMP-activated protein kinase. Trends Biochem Sci 24:22–5
   PubMed Web of Science ®Google Scholar
• Kissebah AH. (1997). Central obesity: Measurement and metabolic effects. Diabetes Rev 5:8–20
   Google Scholar
• Kralisch S, Fasshauer M. (2013). Adipocyte fatty acid binding protein: A novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia 56:10–21
   PubMed Web of Science ®Google Scholar
• Kubota N, Terauchi Y, Miki H, et al. (1999). PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597–609
   PubMed Web of Science ®Google Scholar
• Long YC, Zierath JR. (2006). AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116:1776–83
   PubMed Web of Science ®Google Scholar
• Murphy JE, Zhou S, Giese K, et al. (1997). Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc Natl Acad Sci USA 94:13921–6
   PubMed Web of Science ®Google Scholar
• Nedvídková J, Smitka K, Kopský V, Hainer V. (2005). Adiponectin, an adipocyte-derived protein. Physiol Res 54:133–40
   PubMed Web of Science ®Google Scholar
• Okuno A, Tamemoto H, Tobe K, et al. (1998). Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101:1354–61
   PubMed Web of Science ®Google Scholar
• Otto TC, Lane MD. (2005). Adipose development: From stem cell to adipocyte. Crit Rev Biochem Mol Biol 40:229–42
   PubMed Web of Science ®Google Scholar
• Padmalayam I, Suto M. (2013). Role of adiponectin in the metabolic syndrome: Current perspectives on its modulation as a treatment strategy. Curr Pharm Des 19:5755–63
   PubMed Web of Science ®Google Scholar
• Schreurs M, Kuipers F, van der Leij FR. (2010). Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes Rev 11:380–8
   PubMed Web of Science ®Google Scholar
• Shin SS, Park D, Lee HY, et al. (2012). The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica reduces obesity via skeletal muscle AMPK and PPARα. Pharm Biol 50:506–15
   PubMed Web of Science ®Google Scholar
• Shin SS, Yoon M. (2012). The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits high-fat diet-induced hepatic steatosis via hepatic PPARα activation. Pharm Biol 50:1261–8
   PubMed Web of Science ®Google Scholar
• Spiegelman BM, Flier JS. (1996). Adipogenesis and obesity: Rounding out the big picture. Cell 87:377–89
   PubMed Web of Science ®Google Scholar
• Ukkola O, Santaniemi M. (2002). Adiponectin: A link between excess adiposity and associated comorbidities? J Mol Med 80:696–702
   PubMed Web of Science ®Google Scholar
• Vazque M, Roglans N, Cabrero A, et al. (2001). Bezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue. Mol Cell Biochem 216:71–8
   PubMed Web of Science ®Google Scholar
• Wickelgren I. (1998). Obesity: How big a problem? Science 280:1364–7
   PubMed Web of Science ®Google Scholar
• Xue J, Ding W, Liu Y. (2010). Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice. Fitoterapia 81:173–7
   PubMed Web of Science ®Google Scholar
• Yoon M. (2009). The role of PPARα in lipid metabolism and obesity: Focusing on the effects of estrogen on PPARα actions. Pharmacol Res 60:151–9
   PubMed Web of Science ®Google Scholar
• Yoon M. (2010). PPARα in obesity: Sex difference and estrogen involvement. PPAR Res 2010:584296
   PubMed Web of Science ®Google Scholar
• Yoon KH, Lee HY, Jung YS, et al. (2010). Modulation of obesity by Gyeongshingangjeehwan 18 in ob/ob mice. Korean J Herb 25:1–9
   Google Scholar
• Yoon M, Jeong S, Lee H, et al. (2003). Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice. Biochem Biophys Res Commun 302:29–34
   PubMed Web of Science ®Google Scholar
• Yoon M, Jeong S, Nicol CJ, et al. (2002). Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism. Exp Mol Med 34:481–8
   PubMed Web of Science ®Google Scholar
• You JS, Sung MJ, Chang KJ. (2009). Evaluation of 8-week body weight control program including sea tangle (Laminaria japonica) supplementation in Korean female college students. Nutr Res Pract 3:307–14
   PubMed Web of Science ®Google Scholar
• Zheng CD, Duan YQ, Gao JM, Ruan ZG. (2010). Screening for anti-lipase properties of 37 traditional Chinese medicinal herbs. J Chin Med Assoc 73:319–24
   PubMed Web of Science ®Google Scholar